Follow
Virginia Barbour
Virginia Barbour
Verified email at Qut.edu.au
Title
Cited by
Cited by
Year
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials
KF Schulz, DG Altman, D Moher
Journal of Pharmacology and pharmacotherapeutics 1 (2), 100-107, 2010
226602010
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials
D Moher, S Hopewell, KF Schulz, V Montori, PC Gøtzsche, PJ Devereaux, ...
Bmj 340, 2010
11858*2010
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
D Moher, A Liberati, J Tetzlaff, DG Altman, Prisma Group
International journal of surgery 8 (5), 336-341, 2010
111502010
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
TC Hoffmann, PP Glasziou, I Boutron, R Milne, R Perera, D Moher, ...
Bmj 348, 2014
78382014
CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration
S Hopewell, M Clarke, D Moher, E Wager, P Middleton, DG Altman, ...
PLoS medicine 5 (1), e20, 2008
7532008
Potential predatory and legitimate biomedical journals: can you tell the difference? A cross-sectional comparison
L Shamseer, D Moher, O Maduekwe, L Turner, V Barbour, R Burch, ...
BMC medicine 15, 1-14, 2017
4272017
The Hong Kong Principles for assessing researchers: Fostering research integrity
D Moher, L Bouter, S Kleinert, P Glasziou, MH Sham, V Barbour, ...
PLoS biology 18 (7), e3000737, 2020
4152020
Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration
V Welch, M Petticrew, J Petkovic, D Moher, E Waters, H White, P Tugwell, ...
Journal of clinical epidemiology 70, 68-89, 2016
2492016
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
TC Hoffmann, PP Glasziou, I Boutron, R Milne, R Perera, D Moher, ...
Gesundheitswesen (Bundesverband der Arzte des Offentlichen …, 2016
174*2016
Retractions: guidance from the Committee on Publication Ethics (COPE)
E Wager, V Barbour, S Yentis, S Kleinert
Maturitas 64 (4), 201-203, 2009
1622009
UK Biobank: a project in search of a protocol?
V Barbour
The Lancet 361 (9370), 1734-1738, 2003
1212003
Making sense of non-financial competing interests
PLoS Medicine Editors
PLoS Medicine 5 (9), e199, 2008
1092008
Nephrotic syndrome associated with sulphasalazine.
VM Barbour, PF Williams
BMJ: British Medical Journal 301 (6755), 818, 1990
721990
Time to treat the climate and nature crisis as one indivisible global health emergency
K Abbasi, P Ali, V Barbour, T Benfield, K Bibbins-Domingo, S Hancocks, ...
The Lancet 402 (10413), 1603-1606, 2023
702023
α-Thalassemia resulting from a negative chromosomal position effect
VM Barbour, C Tufarelli, JA Sharpe, ZE Smith, H Ayyub, CA Heinlein, ...
Blood, The Journal of the American Society of Hematology 96 (3), 800-807, 2000
602000
Optimal evidence in difficult settings: improving health interventions and decision making in disasters
M Gerdin, M Clarke, C Allen, B Kayabu, W Summerskill, D Devane, ...
PLoS medicine 11 (4), e1001632, 2014
592014
Core competencies for scientific editors of biomedical journals: consensus statement
D Moher, J Galipeau, S Alam, V Barbour, K Bartolomeos, P Baskin, ...
BMC medicine 15, 1-10, 2017
582017
A scoping review of competencies for scientific editors of biomedical journals
J Galipeau, V Barbour, P Baskin, S Bell-Syer, K Cobey, M Cumpston, ...
BMC medicine 14, 1-17, 2016
562016
Impact of a web-based tool (WebCONSORT) to improve the reporting of randomised trials: results of a randomised controlled trial
S Hopewell, I Boutron, DG Altman, G Barbour, D Moher, V Montori, ...
BMC medicine 14, 1-17, 2016
502016
Characterisation of trials where marketing purposes have been influential in study design: a descriptive study
V Barbour, D Burch, F Godlee, C Heneghan, R Lehman, R Perera, ...
Trials 17, 1-10, 2016
462016
The system can't perform the operation now. Try again later.
Articles 1–20